Member Info for lordloadsoflolly

Spantrout - with exceptions though, as I mentioned.

And sadly those boardroom excesses you mention are far from unique to Aim.

Take a dive into Thames Water’s accounts (preferably holding your breath) if you really want to see what extracting the urine looks like.

Spantrout & Morri940 - you couldn’t make it up with Tigtig!

Pebsi - I wouldn’t tar all Aim shares with the same brush. My biggest Aim holding was with H&T (pawnbrokers). They’ve been steadily growing sales & profits for years, almost without exception (except when Covid temporarily forced all their physical stores to close). And earlier this month they received a takeover bid at a 44% premium.

So as well as receiving a c. 5% annual divi yield for years, I’ve more than doubled my capital within a relatively short time. Have to say, I never saw the takeover coming. But I did think it was undervalued, given its consistently good delivery. Sadly, the same cannot be said of IMM to date. Though luckily, my holding here is tiny in comparison.

Well at least Tigtig finally called something right, exiting before this latest SP tank.

Assuming he ever held in the first place of course (doubtful!)

But fear not, he's ready to jump straight back in again the moment there's a flicker of good news. And he'll probably pay a higher price than he sold out for.

That's entertainment.

Thanks spantrout - I can't see those INC warrants being anywhere near the exercise price by September, now Watson's pulled out.

They'll probably just agree yet another extension though. No doubt shafting IMM shareholders even further by increasing any profit split in INC's favour.

I just reported Richar's latest post for being abusive. And thanks to the moderators (AI presumably), it vanished instantly.

Good riddance say I.

Spantrout - my understanding of the INC warrants is that IMM would only need the £700k (or whatever the figure is to exercise) if INC's share price was in the money at the time.

If INC's share price remains below the warrant price and there's no imminent prospect of it improving, IMM can simply walk away (admittedly having already lost money on it by paying to extend the expiry date multiple times).

Spantrout - Tim's wording's quite clever (my caps):

"the Company will undertake measures to limit or defer cash outflows from the business in the near term, (which include the Directors deferring a proportion of their salaries) until such time as the business is able to meet these payments, OR SEEK TO INTRODUCE FURTHER FUNDING TO THE BUSINESS".

So rather than deferring (note: not foregoing) part of their fully justified & extremely meagre salaries, Tim et al may just do another placing

Trebles all round.

Spantrout - whilst the £700k for INC warrants may now be safe, sadly any profit from them looks like a pipe dream.

Indeed, they'll have cost us a fair bit for all those £75k deadline extensions.

So a potential Brucey bonus now looks pretty much out the window. As does any "windfall" from the latest Lanstead financing deal, which is currently heavily underwater.

I think we can forget about those INC warrants ever adding value to IMM’s coffers now.

INC’s “game-changing” Watson deal is off - and in typical Tim fashion there’s NO explanation as to why. If the patent infringement claim was defended so comprehensively, how come it still convinced Watsons not to proceed,Tim, when they were supposedly on the cusp of launching?

INC is now forced to dispose of this launch stock via another channel. And whilst Tim can bang on about DTC being higher margin & providing a ready-made customer database (both true), it’s a far less sustainable option for future growth than Watson would have been.

IMM holders will be interested to see Tim took months before finally admitting INC’s sole sales partner had walked away. Whilst he recently still listed Avion as a partner to IMM, you have to question how committed / long term this relationship is either, given Tim’s economic release of commercial developments.

Maybe. You’d think they’d actually get their facts straight for an awards ceremony though.

Particularly as there only seem to be three nominations in total!

Sounds a bit of a Mickey Mouse event to me.

Skippysb01 - not sure I agree.

I'd have thought it standard practice for the nominees to vet any text pre-publication.

Though in Hex's case, it does all sound like it was written some time ago. In which case, could just be sloppy standards from the organisers.

Politikos - most interesting thing with Hex nomination is the accompanying blurb re: first gas target date:

"The Company aims to use the net proceeds raised on Admission to commence scoping studies and test drilling in 2024, with plant construction and production drilling due to commence and complete in 2025, with a first gas target of Q4 2025."

Q4 2025 doesn't sound like summer. Though I guess this text may have been written some time ago, since which timelines have changed?

Xviolet - it isn't a deramp to say the multiple years of silence over any revised trial timing has become a major issue for investors (whether current or potential).

Nor is it anything to do with your claim IMM's a "hot fomo share", which most current long term holders would strongly deny anyway.

The only reason you believe "Tim really should deliver something over the next few months" is because he's set himself a year-end deadline to do so. After which all credibility would be lost.

I wouldn't put it past Tim to sacrifice credibility for another lucrative year in post. Equally, he may finally come up with the goods this year.

As you rightly say, "we shall see".

Snail share?!

The price may not have moved in the right direction since you bought, but SMT can hardly be accused of slow movement. It’s been highly volatile at times in fact.

Had you held since 2016 as I have, you’d have more than tripled your investment - even ignoring the small divi yield. That’s some turbo-charged snail!

Peterpharma - anyone rational can’t really argue about the lack of any revised trial news. It’s totally unacceptable that Tim’s continued to keep us in the dark here all these years.

But rather than calling other shareholders fools or posting constant negativity, please buy a few IMM shares as you suggest, attend the AGM & confront Tim in person. Don’t just talk about it, do it.

I also agree with ilovesushi - it feels odd that someone currently uninvested in IMM would post negatively as often as you. And that you’d also concentrate mainly - if not exclusively - on just this one company. Care to explain?

Admittedly, I’ve also been highly critical & vocal about IMM & Tim in recent years. But the big difference is, I still hold some shares here.

Monteacute - think they’ve actually looked at a 20x dose increase. But I get your point.

And of course, unless a revised trial begins sometime vaguely soon, that TR-1 may continue to prove rather elusive.

Tim’s comms remain patchy to say the least. A few bursts of activity every so often when funds are needed. Then radio silence again. Or just pointless rehashes of old news.

I sincerely hope - if only for the sake of ilovesushi & others - that IMM eventually pulls something out the bag. But I fear that “something” may be little more than Tim’s lunchtime sarnies (roast lobster on wholemeal, topped with caviar).

Ilovesushi - 1000% possible returns. But also, 100% possible losses.

I lost count of the number of 'ifs' and 'coulds' in your last couple of posts.

Pebsi - Tigger’s living proof how hard it is to make money on Aim with knee-jerk trading.

Not ALL Aim shares are duff though. My biggest holding is in H&T, which has consistently been profitable with growing divis. And just recently, it received a takeover offer at a 44% premium.

In my experience, it’s generally the Aim shares peddling themselves as the next “get rich quick”

scheme which are the ones to avoid like the plague.

Pebsi - Tigger had you fooled for a minute. Really?

Hilarious he may have been. Convincing? Not even for a nanosecond, surely?

Oh well. At least now Tig's gone we know Tim's transformational RNS is imminent.